QSAR, ADMET, Molecular docking and Dynamic studies of natural products as potential inhibitors for Breast Cancer

Simple item page
dc.contributor.authorKERROUZI, Ichraf
dc.date.accessioned2026-01-28T09:31:17Z
dc.date.available2026-01-28T09:31:17Z
dc.date.issued2025
dc.descriptionTHESIS Presented for graduation from MASTER 2 Field: Process Engineering Option: Pharmaceutical Process Engineeringen_US
dc.description.abstractThis study was conducted to support the ongoing search for novel molecules effective enough to treat breast cancer derived from Trigonella foenum-graecum, Curcuma longa L., and Atriplex Halimus. The study combined computational techniques and computer simulations to evaluate their efficacy, as well as Fourier transform infrared (FTIR) and ultraviolet/visible (UV/VIS) spectroscopy of plant extract. Quantitative structure-activity relationship (QSAR) modeling was used to predict bioactivity; with 2D_3D-QSAR models developed using multiple linear regression (MLR) and support vector regression (SVR). Comparative analysis revealed that MLR outperformed SVR, achieving an R² value of 0.93, an RMSE value of 0.163, and a high Q² value of 0.87, demonstrating superior predictive accuracy. Model predictions were validated using cross-validation. Molecular docking simulations evaluated the binding interactions with key breast cancer targets (HER2, CDK4, AKT1, and MCF-7), revealing strong affinities ranging from -7 to -11.4 kcal/mol. Furthermore, in conjunction with the density functional theory (DFT) method (B3LYP/6- 311G(d,p)), molecular docking identified two promising candidates, fenugreekine and diosgenin, derived from fenugreek, which demonstrated potent inhibition of all proteins compared to the FDA-approved drugs Ibrance and Capivasertib, respectively. ADMET (absorption, distribution, metabolism, excretion, and toxicity) analysis of diosgenin, curcumin, and arbutin demonstrated their pharmacokinetic affinity and safety, making them promising candidates for further experimental validationen_US
dc.identifier.urihttp://dspace.univ-chlef.dz/handle/123456789/2283
dc.publisherOTMANINE Khaleden_US
dc.subjectBreast canceen_US
dc.subject2D_3D-QSARen_US
dc.subjectMolecular Dockingen_US
dc.titleQSAR, ADMET, Molecular docking and Dynamic studies of natural products as potential inhibitors for Breast Canceren_US
dc.typeThesisen_US

Files

Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Qsar,Admet ,molecular docking and dynamic studies of nutural products as potential inhibitors for breast cancer.pdf
Size:
8.58 MB
Format:
Adobe Portable Document Format
Description:
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

Master II en Génie des Procédés